Table 1.
Mean values and prevalence | 1986–1987 | 1992–1993 | 1999–2002 | 2006–2008 | P ANOVA |
---|---|---|---|---|---|
n = 1391 | n = 953 | n = 1096 | n = 1525 | ||
Mean systolic BP, mmHg | 141.8 (20.4) | 142.5 (22.2) | 140.6 (21.7) | 145.5*, **, *** (22.2) | <0.001 |
Mean BMI, kg/m2 | 27.6 (3.92) | 27.1 (4.10) | 27.7** (4.64) | 28.1*, ** (5.13) | <0.001 |
Mean total cholesterol, mmol/L | 6.12 (1.12) | 6.03 (1.23) | 5.93* (1.32) | 5.62*, **, *** (1.11) | <0.001 |
Mean LDL cholesterol, mmol/L | 4.19 (1.13) | 4.04* (1.10) | 3.77*, ** (1.30) | 3.51*, **, *** (1.03) | <0.001 |
Mean HDL cholesterol, mmol/L | 1.29 (0.45) | 1.32 (0.44) | 1.41*, ** (0.42) | 1.37* (0.42) | <0.001 |
Mean triglycerides, mmol/L | 1.43 (0.82) | 1.46 (1.04) | 1.66*, ** (1.01) | 1.81*, **, *** (1.12) | <0.001 |
Mean SCOREa value, % | 4.75 (4.86) | 4.75 (4.94) | 4.61 (4.89) | 5.25*** (5.36) | 0.005 |
P from chi squared | |||||
Arterial hypertension, % | 62.7 | 63.2 | 61.7 | 74.0*, **, *** | <0.001 |
Regular smoking, % | 36.5 | 34.2 | 39.4 | 44.6*, **, *** | <0.001 |
Total cholesterol ≥5.0 mmol/L, % | 85.7 | 78.9* | 76.1* | 70.2*, **, *** | <0.001 |
LDL cholesterol ≥3.0 mmol/L, % | 86.1 | 83.9 | 70.4*, ** | 68.2*, ** | <0.001 |
HDL cholesterol <1.0 mmol/L, % | 27.9 | 23.6 | 14.9*, ** | 15.0*, ** | <0.001 |
Triglycerides ≥1.7 mmol/L, % | 24.8 | 25.5 | 36.3*, ** | 44.6*, **, *** | <0.001 |
Normal weight, BMI <25.0 kg/m2, % | 25.8 | 32.6* | 28.4 | 29.0 | |
Overweight, BMI 25.0–29.9 kg/m2, % | 49.0 | 46.8 | 44.9 | 40.6*, ** | <0.001 |
Obesity, BMI ≥30.0 kg/m2, % | 25.2 | 20.6 | 26.7** | 30.5*, ** | |
SCOREa (%): | |||||
0 % | 7.4 | 6.7 | 8.0 | 8.8 | 0.001 |
1–4 % | 54.2 | 53.9 | 56.0 | 47.2*, **, *** | |
5–9 % | 25.3 | 27.3 | 23.4 | 28.7*** | |
≥10 % | 13.1 | 12.2 | 12.6 | 15.3 |
Abbreviations: CVD cardiovascular disease, BMI body mass index, BP blood pressure, SD standard deviation, HDL high-density lipoproteins, LDL low-density lipoproteins, SCORE Systematic Coronary Risk Evaluation
*p < 0.05 compared to 1986–1987, Bonferroni test
**p < 0.05 compared to 1992–1993, Bonferroni test
***p < 0.05 compared to 1999–2002, Bonferroni test
awithout CVD, other risk factors presented for all participants